Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency

Free Radical Biology and Medicine

Volumn 34, Issue 8, 2003, Pages 969-986

  Xie, Keping ^a   Huang, Suyun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Free radicals; Metastasis; Nitric oxide; Nitric oxide synthase II; Therapy

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; APOPTOSIS; CANCER PREVENTION; CELL SURVIVAL; CYTOTOXICITY; DRUG EFFECT; HOST CELL; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL CULTURE;

EID: 0037446221     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01364-3     Document Type: Review

References (215)

1. Fidler I.J. Critical factors in the biology of human cancer metastasis twenty-eighth G.H.A. Clowes Memorial Award Lecture . Cancer Res. 50:1990;6130-6138.
2. Willis R.A. The spread of tumors in the human body. 1972;Butterworth, London.
3. Sugarbaker E.V. Cancer metastasis a product of tumor-host interactions . Curr. Probl. Cancer. 3:1979;1-59.
4. Weiss L. Principles of metastasis. 1985;Academic Press, Orlando.
5. Fidler I.J., Balch C.M. The biology of cancer metastasis and implications for therapy. Curr. Probl. Surg. 24:1987;137-209.
6. Jain R.K. Barriers to drug delivery in solid tumors. Sci. Am. 271:1994;58-65.
7. Fidler I.J. Biologic heterogeneity of cancer metastases. Breast Cancer Res. Treat. 9:1987;17-26.
8. Fidler I.J. Modulation of the organ microenvironment for the treatment of cancer metastasis. (Editorial) J. Natl. Cancer Inst. 84:1995;1588-1592.
9. Price J.E., Aukerman S.L., Fidler I.J. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res. 46:1986;5172-5178.
10. Aukerman S.L., Price J.E., Fidler I.J. Different deficiencies in the prevention of tumorigenic-low metastatic murine K-1735 melanoma cells from producing metastases. J. Natl. Cancer Inst. 77:1986;915-924.
11. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:1993;541-573.
12. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors a review . Cancer Rev. 49:1989;6449-6465.
13. Boucher Y., Baxter L.T., Jain R.K. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors implications for therapy . Cancer Res. 50:1990;4478-4484.
14. Liotta L.A., Kleinerman J., Saidel G.M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34:1974;997-1004.
15. Liotta L.A., Stetler-Stevenson W.G. Tumor invasion and metastasis an imbalance of positive and negative regulation . Cancer Res. 51:1991;5054s-5059s.
16. Shi Q., Xie K. Experimental animal models for pancreatic cancer. Int. J. Oncol. 17:2000;217-225.
17. Xie K., Wang B., Shi Q., Abbruzzeze J.L., Xiong Q., Le X. Mouse models of metastatic pancreatic adenocarcinoma. Int. J. Pancreatol. 29:2001;21-27.
18. Weiss L. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 11:1992;227-235.
19. 125I-5-iodo-2′-deoxyuridine . J. Natl. Cancer Inst. 45:1970;773-782.
20. Glaves D. Intravascular death of disseminated cancer cells mediated by superoxide anion. Invasion Metastasis. 6:1986;101-111.
21. Paris S., Chauzy C., Martin-Vandelet N., Delpech B., Thiberville L., Martin J.P., Diarra-Mehrpour M. A model of spontaneous lung metastases visualised in fresh host tissue by green fluorescent protein expression. Clin. Exp. Metastasis. 17:1999;817-822.
22. Chishima T., Miyagi Y., Wang X., Yamaoka H., Shimada H., Moossa A.R., Hoffman R.M. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res. 57:1997;2042-2047.
23. Naumov G.N., Wilson S.M., MacDonald I.C., Schmidt E.E., Morris V.L., Groom A.C., Hoffman R.M., Chambers A.F. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J. Cell Sci. 112:1999;1835-1842.
24. Weiss L. Metastasis of cancer a conceptual history from antiquity to the 1990s . Cancer Metastasis Rev. 19:2000;I-XI. 193-383.
25. Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 197:1977;893-895.
26. Zetter B.R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 322:1990;605-612.
27. Talmadge J.E., Fidler I.J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst. 69:1982;975-980.
28. Liotta L.A., Kleinerman J., Saidel G.M. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 36:1976;889-894.
29. Radinsky R. Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Metastasis Rev. 12:1993;345-361.
30. Sato H., Suzuki M. Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer. Weiss L. Fundamental aspects of metastasis. 1976;311-317 North-Holland, Amsterdam.
31. Fidler I.J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer. 9:1973;223-227.
32. Hofmann M., Rudy W., Zoller M., Tolg C., Ponta H., Jerrlich P., Gunthert U. CD44 splice variants confer metastatic behavior in rats homologous sequences are expressed in human tumor cell lines . Cancer Res. 51:1991;5292-5297.
33. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:1991;173-185.
34. Karpatkin S., Pearlstein E. Role of platelets in tumor cell metastasis. Ann. Intern. Med. 95:1981;636-674.
35. Gasic G.J. Role of plasma, platelets and endothelial cells in tumor metastasis. Cancer Metastasis Rev. 3:1984;99-105.
36. Fidler I.J., Bucana C. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res. 37:1977;3945-3956.
37. Wiltrout R.H., Frost P., Morrison M.K., Kerbel R.S. Immune-mediated arrest and reversal of established visceral metastasis in athymic mice. Cancer Res. 39:1979;4034-4039.
38. Hanna N., Fidler I.J. The role of natural killer cells in the destruction of circulating tumor emboli. J. Natl. Cancer Inst. 65:1980;801-809.
39. Herberman R.B. Natural killer cells. Prog. Clin. Biol. Res. 288:1989;161-167.
40. Li L., Kilbourn R.G., Adams J., Fidler I.J. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res. 51:1991;2531-2535.
41. Li L., Nicolson G.L., Fidler I.J. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res. 51:1991;245-254.
42. Fidler I.J. Macrophages and metastasis - a biological approach to cancer therapy presidential address . Cancer Res. 45:1985;4714-4721.
43. Dong Z., O'Brian C.A., Fidler I.J. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J. Leukoc. Biol. 53:1993;53-60.
44. Chambers A.F., Schmidt E.E., MacDonald I.C., Morris V.L., Groom A.C. Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. J. Natl. Cancer Inst. 84:1992;797-803.
45. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., Groom A.C. Multistep nature of metastatic inefficiency dormancy of solitary cells after successful extravasation and limited survival of early micrometastases . Am. J. Pathol. 153:1998;865-873.
46. Rudin C.M., Thompson C.B. Apoptosis and disease regulation and clinical relevance of programmed cell death . Annu. Rev. Med. 48:1997;267-281.
47. Williams G.T., Smith C.A. Molecular regulation of apoptosis genetic controls on cell death . Cell. 74:1993;777-779.
48. Krammer P.H. The CD95(APO-1/Fas)/CD95L system. Toxicol. Lett. 102-103:1998;131-137.
49. Reed J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17:1999;2941-2953.
50. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:2001;555-562.
51. Albina J.E., Cui S., Mateo R.B., Reichner J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:1993;5080-5085.
52. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191:1993;503-508.
53. Xie K., Fidler I.J. TNF-mediated cytotoxicity in sensitive and resistant L929 fibroblasts correlates with nitric oxide-independent and -dependent mechanisms, respectively. J. Leukoc. Biol. 3:(Suppl.):1992;45.
54. Xie K., Huang S., Dong Z., Fidler I.J. Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int. J. Oncol. 3:1993;1043-1047.
55. Lin K.T., Xue J.Y., Nomen M., Spur B., Wong P.Y. Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem. 270:1995;16487-16490.
56. Fehsel K., Kroncke K.-D., Meyer K.L., Huber H., Wahn V., Kolb-Bachofen V. Nitric oxide induces apoptosis in murine thymocytes. J. Immunol. 155:1995;2858-2865.
57. Cui S., Reichner J.S., Mateo R.B., Albina J.E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54:1994;2462-2467.
58. Ankarcrona M., Dypbukt J.M., Brune B., Nicotera P. Interleukin-1 β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213:1994;172-177.
59. Chun S.Y., Eisenhauer K.M., Kubo M., Hsueh A.J. Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology. 136:1995;. 3120-2127.
60. Szabo C., Zingarelli B., O'Connor M., Salzman A.L. DNA strand breakage, activation of poly (ADP-ribose)synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA. 93:1996;1753-1758.
61. Mitrovic B., Ignarro L.J., Vinters H.V., Akers M.A., Schmid I., Uittenbogaart C., Merrill J.E. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience. 65:1995;531-539.
62. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures . Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
63. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
64. Marletta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:1993;12231-12234.
65. Jaffrey S.R., Snyder S.H. Nitric oxide a neural messenger . Annu. Rev. Cell Dev. Biol. 11:1995;417-440.
66. Moncada S. Nitric oxide discovery and impact on clinical medicine . J. R. Soc. Med. 92:1999;164-169.
67. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelial-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:1987;9265-9269.
68. Hibbs J.B. Jr, Taintor R.R., Vavrin Z. Macrophage cytotoxicity role for L-arginine deiminase activity and amino nitrogen to nitrate . Science. 235:1987;473-476.
69. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases structure, function and inhibition . Biochem. J. 357:2001;593-615.
70. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
71. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
72. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
73. Adcock I.M., Brown C.R., Kwon O., Barnes P.J. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem. Biophys. Res. Commun. 199:1994;1518-1524.
74. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:1993;605-613.
75. Kolyada A.Y., Savikovsky N., Madias N.E. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages evidence for tissue specificity . Biochem. Biophys. Res. Commun. 220:1996;600-605.
76. Xie K., Dong Z., Fidler I.J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 59:1996;797-803.
77. Xie K., Fidler I.J. Gene therapy with the inducible nitric oxide synthase for induction of apoptosis to control tumor growth and metastasis. Cancer Metastasis Rev. 17:1998;55-75.
78. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1995;1683-1693.
79. Bellocq A., Suberville S., Philippe C., Bertrand F., Perez J., Fouqueray B., Cherqui G., Baud L. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. J. Biol. Chem. 273:1998;5086-5092.
80. Lacza Z., Puskar M., Figueroa J.P., Zhang J., Rajapakse N., Busija D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic. Biol. Med. 31:2001;1609-1615.
81. Dong Z., Staroselsky A.H., Qi X., Xie K., Fidler I.J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54:1994;789-793.
82. Xie K., Wang Y., Huang S., Xu L., Bielenberg D., Salas T., McConkey D.J., Jiang W., Fidler I.J. Nitric oxide-mediated apoptosis of K-1735 murine melanma cells is associated with down-regulation of Bcl-2. Oncogene. 15:1997;771-779.
83. Shi Q., Huang S., Jiang W., Kutach L.S., Ananthaswamy H.N., Xie K. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res. 59:1999;2072-2075.
84. Xie, K.; Wang, B.; Crum, V. E.; Richardson, E. L.; Luo, Y.; Wei, D. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Submitted, 2002.
85. Shi Q., Xiong Q., Wang B., Le X., Khan N.A., Xie K. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res. 60:2000;2579-2583.
86. Wang B., Xiong Q., Shi Q., Le X., Abbruzzese J.L., Xie K. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res. 61:2001;71-75.
87. Wang B., Xiong Q., Shi Q., Le X., Xie K. Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase. Oncogene. 20:2001;6930-6937.
88. Wang B., Xiong Q., Shi Q., Tan D., Le X., Xie K. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer. 91:2001;607-611.
89. Xie Q., Nathan C. The high-output nitric oxide pathway role and regulation . J. Leukoc. Biol. 56:1994;576-582.
90. Pipili-Synetos E., Papageorgiou A., Sakkoula E., Sotiropoulou G., Fotsis T., Karakiulakis G., Maragoudakis M.E. Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol. 116:1995;1829-1834.
91. Yamamoto T., Terada N., Nishizawa Y., Tanaka H., Akedo H., Seiyama A., Shiga T., Kosaka H. Effects of NG-nitro-L-arginine and/or L-arginine on experimental pulmonary metastasis in mice. Cancer Lett. 87:1994;115-120.
92. Yamamoto T., Terada N., Seiyama A., Nishizawa Y., Akedo H., Kosaka H. Increase in experimental pulmonary metastasis in mice by L-arginine under inhibition of nitric oxide production by NG-nitro-L-arginine methyl ester. Int. J. Cancer. 75:1998;140-144.
93. G-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. Jpn. J. Cancer Res. 88:1997;861-866.
94. Berge D.L., Ridder M.D., Verovski V.N., Janssens M.Y., Monsaert C., Storme G.A. Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase. Br. J. Cancer. 84:2001;1122-1125.
95. Tendler D.S., Bao C., Wang T., Huang E.L., Ratovitski E.A., Pardoll D.A., Lowenstein C.J. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res. 61:2001;3682-3688.
96. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
97. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
98. Shi Q., Le X., Peng Z., Tang H., Xiong Q., Wang B., Li X.-C., Abbruzzese J.L., Xie K. Constitutive sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61:2001;4143-4154.
99. Shi Q., Le X., Wang B., Abbruzzese J.L., Xiong Q., He Y., Xie K. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene. 20:2001;3751-3756.
100. Parkins C.S., Hill S.A., Stratford M.R., Dennis M.F., Chaplin D.J. Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp. Physiol. 82:1997;361-368.
101. Dormandy T.L. Free-radical pathology and medicine. A review. J. R. Coll. Physicians Lond. 23:1989;221-227.
102. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23:1993;21-48.
103. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA. 93:1996;. 6770-6704.
104. Rocha M., Kruger A., Van Rooijen N., Schirrmacher V., Umansky V. Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int. J. Cancer. 63:1995;405-411.
105. Edmiston K.H., Shoji Y., Mizoi T., Ford R., Nachman A., Jessup J.M. Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells. Cancer Res. 58:1998;1524-1531.
106. Wang H.H., McIntosh A.R., Hasinoff B.B., Rector E.S., Ahmed N., Nance D.M., Orr F.W. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity a natural hepatic defense against metastasis . Cancer Res. 60:2000;5862-5869.
107. Dong Z., Qi X., Xie K., Fidler I.J. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccride-responsive and lipopolysaccride-nonresponsive murine macrophages. J. Immunol. 151:1993;2717-2724.
108. Dong Z., Yang X., Xie K., Juang S.-H., Llansa N., Fidler I.J. Activation of inducible nitric oxide synthase in the murine macrophages by interferon-gamma and lipopolysacchride required protein phosphatase I and protein phosphatase 2A activities. J. Leukoc. Biol. 58:1995;725-732.
109. Umansky V., Schirrmacher V. Nitric oxide-induced apoptosis in tumor cells. Adv. Cancer Res. 82:2001;107-131.
110. Farias-Eisner R., Sherman M.P., Aeberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;9407-9411.
111. Xie K., Huang S., Dong Z., Gutman M., Fidler I.J. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res. 55:1995;3123-3131.
112. Radomski M.K., Jenkins D.C., Holmes L., Moncada S. Human colorectal adenocarcinoma cells differential nitric oxide synthesis determines their ability to aggregate platelets . Cancer Res. 51:1991;6073-6077.
113. Kripke M.L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst. 63:1979;541-545.
114. Fidler I.J., Gruys E., Cifone M.A., Barnes Z., Bucana C.D. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst. 67:1981;947-956.
115. Staroselsky A.H., Pathak S., Chernajovsky Y., Tucker S.I., Fidler I.J. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res. 51:1991;6292-6297.
116. Burdelya L.G., Grosheva I.A., Dyakova N.A., Deichman G.I. Nonactivated macrophage-induced nitric oxide production by tumor cells differing in tumorigenic and spontaneous metastatic activities. Tumour Biol. 19:1998;346-355.
117. Xie K., Huang S., Dong Z., Juang S.-H., Gutman M., Xie Q.-W., Nathan C., Fidler I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma cells. J. Exp. Med. 181:1995;1333-1343.
118. George D. Platelet-derived growth factor receptors apeutic target in solid tumors . Semin. Oncol. 28:2001;27-33.
119. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:1990;5193-5197.
120. Tsuruo T., Kawabata H., Iida H., Yomori T. Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastasis. 7:1986;25-29.
121. Radomski M.W., Jenkins D.C., Holmes L., Moncada S. Human colorectal adenocarcinoma cells differential nitric oxide synthesis determines their ability to aggregate platelets . Cancer Res. 51:1991;6073-6078.
122. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature. 327:1987;524-526.
123. Hart I.R., Saini A. Biology of tumor metastases. Lancet. 339:1992;1437-1453.
124. Kong L., Dunn G.D., Keefer L.K., Korthuis R.J. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin. Exp. Metastasis. 14:1996;335-343.
125. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-68.
126. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271:1996;11317-11324.
127. Korbut R., Gryglewski R.J. Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur. J. Pharmacol. 234:1993;17-22.
128. Sakkoula E., Haralabopoulos G., Andriopoulou P., Mragoudakis M.E. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111:1994;894-902.
129. Perretti M., Szabo C., Thiemermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116:1995;2251-2257.
130. Pipili-Synetos E., Sakkoula E., Maragoudakis M.E. Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108:1993;855-857.
131. Xie K., Fidler I.J. Decreased matrix metalloproteinase-2 (MMP-2) expression correlates with suppressin of tumorigenicity and metastasis of K-1735 murine melanoma cells transfected with the inducible nitric oxide synthase (iNOS) gene. Proc. Am. Assoc. Cancer Res. 38:1999;1113.
132. Nunokawa Y., Tanaka S. Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem. Biophys. Res. Commun. 188:1992;409-415.
133. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., Webb R.C. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78:1996;225-230.
134. Kourembanas S., McQuillan L.P., Leung G.K., Faller D.V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:1993;99-104.
135. Tuder R.M., Flook B.E., Voelkel N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1995;1798-1807.
136. Doi K., Akaike T., Horie H., Noguchi Y., Fujii S., Beppu T., Ogawa M., Maeda H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer. 77:1996;1598-1604.
137. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94:1994;2036-2044.
138. Leibovich S.J., Polverini P.J., Fong T.W., Harlow L.A., Koch C.J. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA. 91:1994;4190-4194.
139. Fukuo K., Inoue T., Morimoto S., Nakahashi T., Yasuda O., Kitano S., Sasada R., Ogihara T. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J. Clin. Invest. 95:1995;669-676.
140. Andrew P.J., Harant H., Lindley I.J. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214:1995;949-956.
141. Xiong Q., Shi Q., Le X., Wang B., Abbruzzeze J.L., Xie K. Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma. J. Interferon Cytokine Res. 21:2001;529-537.
142. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12:2001;375-391.
143. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711-721.
144. Chinje E.C., Stratford I.J. Role of nitric oxide in growth of solid tumours a balancing act . Essays Biochem. 32:1997;61-72.
145. Denhardt D.T., Chambers A.F. Overcoming obstacles to metastasis - defenses against host defenses osteopontin (OPN) as a shield against attack by cytotoxic host cells . J. Cell. Biochem. 56:1994;48-51.
146. Feng B., Rollo E.E., Denhardt D.T. Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity evidence from cell lines down-regulated for OPN expression by a targeted ribozyme . Clin. Exp. Metastasis. 13:1995;453-462.
147. Moon B.K., Lee Y.J., Battle P., Jessup J.M., Raz A., Kim H.R. Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis implication of galectin-3 function during metastasis . Am. J. Pathol. 159:2001;1055-1060.
148. Kim Y.M., de Vera M.E., Watkins S.C., Billiar T.R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272:1997;1402-1411.
149. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1555.
150. Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine nitric oxide pathway . Acta Physiol. Scand. 145:1992;201-227.
151. Kwon N.S., Stuehr D.J., Nathan C.F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:1991;761-767.
152. Kurose I., Miura S., Fukumura D., Yonei Y., Saito H., Tada S., Suematsu M., Tsuchiya M. Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells a comparison with oxidative burst . Cancer Res. 53:1993;2676-2682.
153. Kitajima I., Kawahara K., Nakajima T., Soejima Y., Matsuyama T., Maruyama I. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204:1995;244-251.
154. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic beta cells. Diabetes. 44:1995;. 733-378.
155. Dunger A., Augstein P., Schmidt S., Fischer U. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA. J. Autoimmun. 9:1996;309-313.
156. Gansauge S., Nussler A.K., Beger H.G., Gansauge F. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 9:1998;611-617.
157. Mortensen K., Skouv J., Hougaard D.M., Larsson L.I. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274:1999;37679-37684.
158. Binder C., Schulz M., Hiddemann W., Oellerich M. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. Lab. Invest. 79:1999;1703-1712.
159. Ho Y.S., Lee H.M., Mou T.C., Wang Y.J., Lin J.K. Suppression of nitric oxide-induced apoptosis by N-acetyl-L-cysteine through modulation of glutathione, bcl-2, and bax protein levels. Mol. Carcinog. 19:1997;101-113.
160. Kwak J.Y., Han M.K., Choi K.S., Park I.H., Park S.Y., Sohn M.H., Kim U.H., McGregor J.R., Samlowski W.E., Yim C.Y. Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell. Immunol. 203:2000;84-94.
161. Sveinbjornsson B., Olsen R., Seterne O.M., Seljelid R. Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem. Biophys. Res. Commun. 223:1996;643-649.
162. Geng Y.J., Hellstrand K., Wennmalm A., Hansson G.K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to IFN-γ and TNF-α Cancer Res. 56:1996;866-874.
163. Filep J.G., Baron C., Lachance S., Perreault C., Chan J.S. Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells. Blood. 87:1996;5136-5143.
164. Xiao L., Eneroth P.H., Qureshi G.A. Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand. J. Immunol. 42:1995;505-511.
165. Cifone M.G., Festuccia C., Cironi L., Cavallo G., Chessa M.A., Pensa V., Tubaro E., Santoni A. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell. Immunol. 157:1994;181-194.
166. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J. Neuropathol. Exp. Neurol. 55:1996;36-43.
167. Palluy O., Rigaud M. Nitric oxide induces cultured cortical neuron apoptosis. Neurosci. Lett. 208:1996;1-4.
168. Martin-Sanz P., Diaz-Guerra M.J., Casado M., Bosca L. Bacterial lipopolysaccharide antagonizes transforming growth factor beta 1-induced apoptosis in primary cultures of hepatocytes. Hepatology. 23:1996;1200-1207.
169. Fukuo K., Hata S., Suhara T., Nakahashi T., Shinto Y., Tsujimoto Y., Morimoto S., Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 27:1996;823-826.
170. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:1995;75-85.
171. Shimaoka M., Iida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209:1995;519-526.
172. Messmer U.K., Lapetina E.G., Brune B. Nitric oxide-induced apoptosis in RAW264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:1995;757-765.
173. Laubach V.E., Garvey E.P., Sherman P.A. High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. Biochem. Biophys. Res. Commun. 218:1996;802-807.
174. Ambs S., Merriam W.G., Ogunfusika M.O., Bennett W.P., Ishibe N., Hussain S.P., Tzeng E.E., Geller D.A., Billiar T.R., Harris C.C. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat. Med. 4:1998;1371-1376.
175. Brune B., Mohr S., Messmer U.K. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev. Physiol. Biochem. Pharmacol. 127:1996;1-30.
176. Ho Y.S., Wang Y.J., Lin J.K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog. 16:1996;20-31.
177. Korsmeyer, S. J. Programmed cell death and the regulation of homeostasis. Harvey Lect. 95:21-41; 1999-2000.
178. Reed J.C. Mechanisms of apoptosis. Am. J. Pathol. 157:2000;1415-1430.
179. Hockenbery D.M. Bcl-2, a novel regulator of cell death. Bioessays. 17:1995;631-638.
180. Xie K., Huang S., Wang Y., Beltran P.J., Juang S.H., Dong Z., Reed J.C., McDonnell T.J., McConkey D.J., Fidler I.J. Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. Cancer Immunol. Immunother. 43:1996;109-115.
181. Albina J.E., Martin B.A., Henry W.L. Jr, Louis C.A., Reichner J.S. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity. J. Immunol. 157:1996;279-283.
182. Messmer U.K., Reed U.K., Brune B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271:1996;20192-20197.
183. Chang C.I., Liao J.C., Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 61:2001;1100-1106.
184. Mackenzie-Graham A.J., Mitrovic B., Smoll A., Merrill J.E. Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev. Neurosci. 16:1994;162-171.
185. Espey M.G., Miranda K.M., Pluta R.M., Wink D.A. Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J. Biol. Chem. 275:2000;11341-11347.
186. Wink D.A., Miranda K.M., Espey M.G. Cytotoxicity related to oxidative and nitrosative stress by nitric oxide. Exp. Biol. Med. (Maywood). 226:2001;621-623.
187. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9:1996;836-844.
188. Petit J.F., Nicaise M., Lepoivre M., Guissani A., Lemaire G. Protection by glutathione against the antiproliferative effects of nitric oxide. Dependence on kinetics of no release. Biochem. Pharmacol. 52:1996;205-212.
189. Schwarz M.A., Lazo J.S., Yalowich J.C., Allen W.P., Whitmore M., Bergonia H.A., Tzeng E., Billiar T.R., Robbins P.D., Lancaster J.R. Jr, Pitt B.R. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA. 92:1995;4452-4456.
190. Farias-Eisner R., Chaudhuri G., Aeberhard E., Fukuto J.M. The chemistry and tumoricidal activity of nitric oxide/hydrogen peroxide and the implications to cell resistence/susceptibility. J. Biol. Chem. 271:1996;6144-6151.
191. Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11:1997;443-448.
192. Shi Q., Huang S., Jiang W., Kutach L.S., Ananthaswamy H.N., Xie K. Direct correlation between nitric oxide synthase II inducibility an d metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res. 59:1999;2072-2075.
193. Xie K., Huang S., Wang Y., Dong Z., Juang S.-H., Reed J.C., McDonnell T.J., McConkey D.J., Fidler I.J. Bcl-2 protects cytokine-induced nitric oxide-dependent apoptosis. Cancer Immunol. Immunother. 43:1996;109-115.
194. Brockhaus F., Brune B. U937 apoptotic cell death by nitric oxide Bcl-2 downregulation and caspase activation . Exp. Cell Res. 238:1998;33-41.
195. Sandau K., Pfeilschifter J., Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 52:1997;378-386.
196. Ho Y.S., Liu H.L., Duh J.S., Chen R.J., Ho W.L., Jeng J.H., Wang Y.J., Lin J.K. Induction of apoptosis by S-nitrosoglutathione and Cu2+ or Ni2+ ion through modulation of bax, bad, and bcl-2 proteins in human colon adenocarcinoma cells. Mol. Carcinog. 26:1999;201-211.
197. Ing D.J., Zang J., Dzau V.J., Webster K.A., Bishopric N.H. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ. Res. 84:1999;21-33.
198. von Knethen A., Brockhaus F., Kleiter I., Brune B. NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression. Mol. Med. 5:1999;672-684.
199. Umansky V., Ushmorov A., Ratter F., Chlichlia K., Bucur M., Lichtenauer A., Rocha M. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas). Int. J. Oncol. 16:2000;109-117.
200. Chlichlia K., Peter M.E., Rocha M., Scaffidi C., Bucur M., Krammer P.H., Schirmacher V., Umansky V. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood. 91:1998;4311-4320.
201. Kim Y.M., de Vera M.E., Watkins S.C., Billiar T.R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272:1997;1402-1411.
202. Nisoli E., Regianini L., Bulbarelli A., Briscini L., Breacale R., Carruba M.O. Protective effects of noradrenaline against tumor necrosis factor-alpha-induced apoptosis in cultured rat brown adipocytes role of nitric oxide-induced heat shock protein 70 expression . Int. J. Obes. Relat. Metab. Disord. 25:2001;1421-1430.
203. Mannick J.B., Asano K., Izumi K., Kieff E., Stamler J.S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
204. Genaro A.M., Hortelano S., Alvarez A., Martinez C., Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95:1995;1884-1890.
205. Saavedra J.E., Billiar T.R., Williams D.L., Kim Y.M., Watkins S.C., Keefer L.K. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J. Med. Chem. 40:1997;1947-1954.
206. Tzeng E., Billiar T.R., Williams D.L., Li J., Lizonova A., Kovesdi L., Kim Y.M. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery. 124:1998;278-283.
207. Orucevic A., Lala P.K. Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome. Cancer Metastasis Rev. 17:1998;127-142.
208. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumor progression. Lancet Oncol. 2:2001;149-156.
209. Xie K., Huang S., Dong Z., Juang S.-H., Wang Y., Fidler I.J. Destruction of bystander cells by tumor cells transfected with the inducible nitric oxide synthase gene. J. Natl. Cancer Inst. 89:1997;421-427.
210. Huang S., Xie K., Ullrich S.E., Bar-Eli M. Transfection of interleukin-10 suppresses tumorigenicity and metastasis of human melanoma by inhibiting angiogenesis. Clin. Cancer Res. 2:1996;1961-1979.
211. Kundu N., Dorsey R., Jackson M.J., Guiterrez P., Wilson K., Fu S., Ramanujam K., Thomas E., Fulton A.M. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Int. J. Cancer. 76:1998;713-719.
212. Bruns C.J., Shinohara H., Harbison M.T., Davis D.W., Nelkin G., Killion J.J., McConkey D.J., Dong Z., Fidler I.J. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. Cancer Res. 60:2000;2-7.
213. Calderon C., Huang Z.H., Gage D.A., Sotomayor E.M., Lopez D.M. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidylserine. J. Exp. Med. 180:1995;945-958.
214. Juang S.-H., Xie K., Xu L., Shi Q., Wang Y., Yoneda J., Fidler I.J. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther. 9:1998;845-854.
215. Yong W., Yan D., Wang B., Spohn B., Ding D., Shao R., Zou Y., Xie K., Hung M.-C. Suppression of tumor growth and metastasis of human pancreatic adenocarcinoma by p202 gene transfer. Cancer Res. 61:2001;7142-7147.